Cited by

• C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy.

  Yang X, Yuan Y, Shao X, Pang H, Che X, Cao L, Zhang M, Xu Y, Ni Z, Qi C, Wang Q, Mou S. Yang X, et al. Front Med (Lausanne). 2022 Jan 31;9:832998. doi: 10.3389/fmed.2022.832998. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35174193 Free PMC article.
• Molecular Assessment of C4d-Positive Renal Transplant Biopsies Without Evidence of Rejection.

  Dominy KM, Willicombe M, Al Johani T, Beckwith H, Goodall D, Brookes P, Cook HT, Cairns T, McLean A, Roufosse C. Dominy KM, et al. Kidney Int Rep. 2018 Sep 18;4(1):148-158. doi: 10.1016/j.ekir.2018.09.005. eCollection 2019 Jan. Kidney Int Rep. 2018. PMID: 30596178 Free PMC article.
• Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?

  Cicciarelli JC, Lemp NA, Chang Y, Koss M, Hacke K, Kasahara N, Burns KM, Min DI, Naraghi R, Shah T. Cicciarelli JC, et al. J Immunol Res. 2017;2017:1652931. doi: 10.1155/2017/1652931. Epub 2017 Jan 15. J Immunol Res. 2017. PMID: 28182088 Free PMC article.
• Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.

  Kim MK, Maeng YI, Lee SJ, Lee IH, Bae J, Kang YN, Park BT, Park KK. Kim MK, et al. Int J Clin Exp Pathol. 2013 Sep 15;6(10):2157-67. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133594 Free PMC article.
• The spectrum of renal thrombotic microangiopathy in lupus nephritis.

  Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M, Yu F, Liu G, Zhao MH. Song D, et al. Arthritis Res Ther. 2013 Jan 15;15(1):R12. doi: 10.1186/ar4142. Arthritis Res Ther. 2013. PMID: 23320601 Free PMC article.